256 related articles for article (PubMed ID: 22855135)
1. Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group.
Segura PP; Ponce CG; Ramón Y Cajal T; Blanch RS; Aranda E
Clin Transl Oncol; 2012 Aug; 14(8):553-63. PubMed ID: 22855135
[TBL] [Abstract][Full Text] [Related]
2. High risk factors of pancreatic carcinoma.
Camara SN; Yin T; Yang M; Li X; Gong Q; Zhou J; Zhao G; Yang ZY; Aroun T; Kuete M; Ramdany S; Camara AK; Diallo AT; Feng Z; Ning X; Xiong JX; Tao J; Qin Q; Zhou W; Cui J; Huang M; Guo Y; Gou SM; Wang B; Liu T; Olivier OET; Conde T; Cisse M; Magassouba AS; Ballah S; Keita NLM; Souare IS; Toure A; Traore S; Balde AK; Keita N; Camara ND; Emmanuel D; Wu HS; Wang CY
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):295-304. PubMed ID: 27376795
[TBL] [Abstract][Full Text] [Related]
3. Familial Pancreatic Cancer and the Future of Directed Screening.
Welinsky S; Lucas AL
Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
[TBL] [Abstract][Full Text] [Related]
4. Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.
Matsubayashi H
J Gastroenterol; 2011 Nov; 46(11):1249-59. PubMed ID: 21847571
[TBL] [Abstract][Full Text] [Related]
5. Familial pancreatic cancer: Concept, management and issues.
Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
[TBL] [Abstract][Full Text] [Related]
6. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
7. German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.
Rieder H; Sina-Frey M; Ziegler A; Hahn SA; Przypadlo E; Kress R; Gerdes B; Colombo Benkmann M; Eberl T; Grützmann R; Lörken M; Schmidt J; Bartsch DK
Onkologie; 2002 Jun; 25(3):262-6. PubMed ID: 12119461
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
Vasen HF; Wasser M; van Mil A; Tollenaar RA; Konstantinovski M; Gruis NA; Bergman W; Hes FJ; Hommes DW; Offerhaus GJ; Morreau H; Bonsing BA; de Vos tot Nederveen Cappel WH
Gastroenterology; 2011 Mar; 140(3):850-6. PubMed ID: 21129377
[TBL] [Abstract][Full Text] [Related]
10. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
11. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
12. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M;
Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763
[TBL] [Abstract][Full Text] [Related]
13. Early detection markers in Pancreas Cancer.
Farrell JJ; van Rijnsoever M; Elsaleh H
Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
[TBL] [Abstract][Full Text] [Related]
14. A histomorphologic comparison of familial and sporadic pancreatic cancers.
Singhi AD; Ishida H; Ali SZ; Goggins M; Canto M; Wolfgang C; Meriden Z; Roberts N; Klein AP; Hruban RH
Pancreatology; 2015; 15(4):387-391. PubMed ID: 25959245
[TBL] [Abstract][Full Text] [Related]
15. Screening and surgical outcomes of familial pancreatic cancer.
Templeton AW; Brentnall TA
Surg Clin North Am; 2013 Jun; 93(3):629-45. PubMed ID: 23632149
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for familial pancreatic cancer.
de Vos tot Nederveen Cappel WH; Lagendijk MA; Lamers CB; Morreau H; Vasen HF
Scand J Gastroenterol Suppl; 2003; (239):94-9. PubMed ID: 14743890
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
[TBL] [Abstract][Full Text] [Related]
18. Familial pancreatic carcinoma in Jews.
Lynch HT; Deters CA; Lynch JF; Brand RE
Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing by cancer site: pancreas.
Axilbund JE; Wiley EA
Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737
[TBL] [Abstract][Full Text] [Related]
20. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
Torphy RJ; Schulick RD
Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
